PF Warrior Special Clinical Trial Meeting: REVERT IPF: TTI-101

PF Warriors is excited to invite you to a special Zoom clinical trial presentation. Join us to learn about the REVERT IPF, a phase 2 clinical trial to evaluate the safety and effectiveness of TTI-101 for the treatment of idiopathic pulmonary fibrosis (IPF).

Whether you’re a patient, caregiver, or healthcare professional, we hope you can join us for this important conversation on advancing care with idiopathic pulmonary fibrosis.

A short Q&A session with Imran Alibhai, PhD, and John Kauh, MD will follow the presentation.

Topics to be discussed:

• 🔹 Introduction to Tvardi Therapeutics 
• 🔹 Brief review of data from prior studies with TTI-101
• 🔹 Overview of the REVERT IPF Study, including qualification criteria and information on locating study sites.